Hence, we speculate that since Brf2 has been shown to be amplified in breast cancers and has been proposed to be a candidate oncogene [48,49], strict regulation of Brf2 expression could be critical in preventing the oncogenic phenotype. This evidence concerns the gene BRF2 and breast carcinoma.